PLA2G4A and early-onset autosomal dominant Alzheimer disease: Therefore, cPLA2 represents a potential novel therapeutic target to treat a wide range of diseases from cancer to neurodegenerative diseases such as Alzheimer’s disease and multiple sclerosis8,58.